Esperion Therapeutics, Inc.
ESPR
$2.51
-$0.21-7.57%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 167.85M | 92.45M | 86.06M | 114.63M | 144.76M |
| Total Receivables | 140.19M | 118.98M | 107.75M | 81.29M | 80.14M |
| Inventory | 145.99M | 141.84M | 114.47M | 99.32M | 108.35M |
| Prepaid Expenses | 8.54M | 7.20M | 34.32M | 23.53M | 4.74M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 462.57M | 360.46M | 342.60M | 318.78M | 338.00M |
|
|
|||||
| Total Current Assets | 462.57M | 360.46M | 342.60M | 318.78M | 338.00M |
| Net Property, Plant & Equipment | 3.26M | 3.50M | 4.43M | 5.20M | 5.77M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 56.00K | 56.00K | 56.00K | 56.00K | 56.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 465.89M | 364.02M | 347.09M | 324.03M | 343.82M |
|
|
|||||
| Total Accounts Payable | 65.07M | 77.51M | 74.70M | 71.99M | 51.65M |
| Total Accrued Expenses | 23.36M | 20.26M | 16.66M | 23.70M | 24.63M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 89.70M | 152.07M | 123.82M | 114.73M | 104.90M |
| Total Finance Division Other Current Liabilities | 122.68M | 109.19M | 83.61M | 60.55M | 65.05M |
| Total Other Current Liabilities | 122.68M | 109.19M | 83.61M | 60.55M | 65.05M |
| Total Current Liabilities | 300.81M | 359.03M | 298.80M | 270.97M | 246.23M |
|
|
|||||
| Total Current Liabilities | 300.81M | 359.03M | 298.80M | 270.97M | 246.23M |
| Long-Term Debt | 457.65M | 448.15M | 473.05M | 477.30M | 483.74M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 653.00K | 767.00K | 1.31M | 1.97M | 2.57M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.74M | 7.44M | 7.44M | -- | -- |
| Total Liabilities | 767.85M | 815.38M | 780.59M | 750.24M | 732.54M |
|
|
|||||
| Common Stock & APIC | 1.38B | 1.29B | 1.28B | 1.27B | 1.27B |
| Retained Earnings | -1.62B | -1.69B | -1.65B | -1.64B | -1.60B |
| Treasury Stock & Other | -55.00M | -55.00M | -55.00M | -55.00M | -55.00M |
| Total Common Equity | -301.97M | -451.36M | -433.51M | -426.21M | -388.72M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -301.97M | -451.36M | -433.51M | -426.21M | -388.72M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -301.97M | -451.36M | -433.51M | -426.21M | -388.72M |
|
|
|||||